NATALIA PASUMANSKY: Open Payments
NPI 1366417909 · REDMOND, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 13 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $33 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $63 |
| Kowa Pharmaceuticals America, Inc. | 2 | $45 |
| Organogenesis Inc. | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Novo Nordisk Inc | 1 | $28 |
| Hologic Sales and Service, LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: ZORYVE, LINZESS, QULIPTA, Kerendia, Ozempic, VIA MATRIX, APTIMA, JARDIANCE.
Industry payments across WA — which companies pay providers there.
